Target intelligence / Profile preview

Extracellular matrix protein heparan sulfate-binding sites

Molecular classification
Extracellular matrix protein, Binding site, Other
01

Overview

Extracellular matrix protein heparan sulfate-binding sites are specialized structural domains within proteins of the extracellular matrix (ECM), such as fibronectin, laminin, and perlecan, that mediate interactions with heparan sulfate (HS) glycosaminoglycans (Xu and Esko, 2014). These sites typically consist of clusters of basic amino acids, notably lysine and arginine, which form electrostatic bonds with the negatively charged sulfate and carboxyl groups of HS (Cardin and Weintraub, 1989). Biologically, these interactions are essential for the assembly of the ECM and the sequestration of various signaling molecules, including fibroblast growth factors (FGF) and vascular endothelial growth factors (VEGF), thereby regulating their stability and bioavailability (Whitelock and Iozzo, 2005). In disease states like cancer, these sites facilitate tumor progression by acting as a reservoir for pro-angiogenic factors that are released upon ECM degradation by enzymes like heparanase (Kudoh et al., 2010). Furthermore, many viruses and bacteria utilize these HS-binding sites on host ECM proteins or cell surfaces as initial attachment points for infection (Spillmann, 2001). Therapeutic targeting of these sites involves the use of heparin mimetics, such as muparfostat, which competitively inhibit HS-protein interactions to disrupt pathological signaling and inhibit angiogenesis or pathogen entry (Dredge et al., 2010).

Other names
Heparan sulfate-binding domainsHS-binding motifsGAG-binding sitesCardin-Weintraub motifs
02

Mechanism of action

Competitive inhibition of heparan sulfate-protein interactions and displacement of sequestered growth factors

03

Biological functions

Signal transductionCell proliferationExtracellular matrix organizationAngiogenesis regulationOther
04

Disease associations

CancerInflammationInfectionCardiovascular diseaseOther
05

Safety considerations

Anticoagulant effectsThrombocytopeniaOsteoporosisHypersensitivity reactionsImpaired wound healing
06

Interacting drugs

Heparin

5 more in the full profile.

07

Biomarkers

Heparanase-1 expressionSoluble syndecan-1Basic fibroblast growth factor levelsVascular endothelial growth factor levels

Beyond the preview

Go deeper on Extracellular matrix protein heparan sulfate-binding sites.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix protein heparan sulfate-binding sites.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call